1
ChemoCentryx Inc. agreed to pay $35 million to settle an investor class action over alleged false statements it made regarding the safety of its vasculitis drug (news.bloomberglaw.com)
submitted 7 months ago by to c/Settlements@lemmy.world
comment fedilink hide all child comments

no comments (yet)

sorted by: hot top controversial new old
there doesn't seem to be anything here